Ceftriaxone-induced acute reversible encephalopathy in a patient with enteric fever
- PMID: 22345886
- PMCID: PMC3271518
- DOI: 10.4103/0253-7613.91884
Ceftriaxone-induced acute reversible encephalopathy in a patient with enteric fever
Abstract
Ceftriaxone is a commonly used, third-generation cephalosporin. Encephalopathy is a rare side effect of third- and fourth-generation cephalosporins. Renal failure and previous disease of the central nervous system predispose to this neurotoxicity. We describe a case of acute transient encephalopathy in a patient treated with ceftriaxone for enteric fever infection. Early detection of this complication is relevant given that stopping the drug usually reverts the neurological syndrome.
Keywords: Adverse drug reaction; ceftriaxone; encephalopathy; neurotoxicity.
Conflict of interest statement
References
-
- Martínez-Rodríguez JE, Barriga FJ, Santamaria J, Iranzo A, Pareja JA, Revilla M, et al. Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am J Med. 2001;111:115–9. - PubMed
-
- Eggers V, Fügener K, Hein OV, Rommelspacher H, Heyes MP, Kox WJ, et al. Antibiotic-mediated release of tumour necrosis factor alphain patients with hospital acquired pneumonia and septic encephalopathy. Intensive Care Med. 2004;30:1544–51. - PubMed
-
- Calandra G, Lydick E, Carrigan J, Weiss L, Guess H. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: Experience with imipenem/cilastatin. Am J Med. 1988;84:911–8. - PubMed
-
- Roncon-Albuquerque R, Jr, Pires I, Martins R, Real R, Sousa G, von Hafe P. Ceftriaxone-induced acute reversible encephalopathy in a patient treated for aurinary tract infection. Neth J Med. 2009;67:72–5. - PubMed
LinkOut - more resources
Full Text Sources